CRON vs TRLV: stock comparison and AI forecast
Cronos Group Inc. (CRON) and Trulieve Cannabis Corp. (TRLV) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CRON Cronos Group Inc.
- Market Cap
- $1.25B
- P/E Ratio
- 19.9x
- Size
- small-cap
- AI Forecast
TRLV Trulieve Cannabis Corp.
- Market Cap
- $2.14B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- TRLV is 1.7 times larger than CRON by market capitalization ($2.14B against $1.25B).
- CRON turns 29.6% of its revenue into net income, against -41.5% for TRLV.
- TRLV carries 1.71 times debt per unit of equity, against 0.06 times for CRON.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CRON | TRLV |
|---|---|---|
| Market Cap | $1.25B | $2.14B |
| P/E Ratio | 19.88x | – |
| P/B Ratio | 1.17x | 2.78x |
| EPS | $0.17 | $-2.44 |
| Book Value/Share | $2.90 | $3.99 |
| Revenue/Share | $0.64 | $5.92 |
| FCF/Share | $0.14 | $1.01 |
Profitability & Margins
| Metric | CRON | TRLV |
|---|---|---|
| ROE | 6.5% | -61.7% |
| ROA | 5.9% | -22.8% |
| ROIC | -0.2% | -14.0% |
| Gross Margin | 34.7% | 59.5% |
| Operating Margin | -1.0% | -24.3% |
| Net Margin | 29.6% | -41.5% |
| EBT Margin | 28.9% | -28.6% |
| Tax Rate | -15.7% | -44.4% |
Financial Health
| Metric | CRON | TRLV |
|---|---|---|
| Current Ratio | 16.18x | 5.94x |
| Quick Ratio | 15.25x | 3.98x |
| D/E Ratio | 0.06x | 1.71x |
| Financial Leverage | 1.10x | 2.71x |
| Interest Coverage | 34.4x | -20.5x |
| Working Capital | $856M | $470M |
Cash Flow
| Metric | CRON | TRLV |
|---|---|---|
| Operating Cash Flow | $60M | $245M |
| Free Cash Flow | $50M | $195M |
| Capital Spending | -$10M | -$50M |
| OCF Growth YoY | 199.9% | 23.8% |
| FCF Growth YoY | – | 116.3% |
| FCF/Sales | 21.0% | 17.1% |
| CapEx/Sales | 4.3% | 4.4% |
Operational Efficiency
| Metric | CRON | TRLV |
|---|---|---|
| Asset Turnover | 0.20x | 0.55x |
| Receivables Turnover | 6.5x | 289.2x |
| Inventory Turnover | – | 2.5x |
| Fixed Assets Turnover | 1.7x | 1.9x |
| Days Sales Outstanding | 57 days | 1 days |
| Days Inventory | – | 148 days |
| Payables Period | – | 49 days |
| Cash Conversion Cycle | – | 100 days |
Income Statement
| Metric | CRON | TRLV |
|---|---|---|
| Total Revenue | $237M | $1.14B |
| Operating Income | -$2M | -$277M |
| Net Income | $70M | -$473M |
| R&D Expense | $5M | – |
| SG&A Expense | $81M | $432M |
| Cost of Goods Sold | – | $462M |
Dividend & Shareholder Information
| Metric | CRON | TRLV |
|---|---|---|
| Shares Outstanding | 368M | 192M |
| Net Income Growth | 278.5% | – |
| EPS Growth | 466.7% | – |
CRON vs TRLV: stock comparison and AI forecast
Which is bigger, CRON or TRLV?
TRLV is 1.7 times larger than CRON by market capitalization ($2.14B against $1.25B).
Which one does Intratio's AI model rank higher, CRON or TRLV?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.